• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水飞蓟提取物(水飞蓟)、熊去氧胆酸或二者联合治疗可减轻大鼠胆汁淤积性肝损伤:肝干细胞的作用。

Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.

作者信息

Alaca Nuray, Özbeyli Dilek, Uslu Serap, Şahin Hasan Hüseyin, Yiğittürk Gürkan, Kurtel Hızır, Öktem Gülperi, Çağlayan Yeğen Berrak

机构信息

Department of Physiotherapy and Rehabilitation, Acıbadem University Faculty of Health Sciences, İstanbul, Turkey.

出版信息

Turk J Gastroenterol. 2017 Nov;28(6):476-484. doi: 10.5152/tjg.2017.16742. Epub 2017 Oct 25.

DOI:10.5152/tjg.2017.16742
PMID:29086715
Abstract

BACKGROUND/AIMS: Cholestasis, which results in hepatic cell death, fibrosis, cirrhosis, and eventually liver failure, is associated with oxidative stress. The aim of this study was to evaluate the effects of milk thistle (MT, Silybum marianum) and ursodeoxycholic acid (UDCA) or their combination on the activation of hepatic stem cells and on the severity of cholestasis liver injury in rats.

MATERIALS AND METHODS

Under anesthesia, bile ducts of female Sprague Dawley rats were ligated (BDL) or had sham operation. BDL rats were administered saline, UDCA (15 mg/kg/d), MT (600 mg/kg/d), or UDCA+MT by gavage for 10 days. On the 11th day, rats were sacrificed and blood and liver samples were obtained. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hepatic malondialdehyde (MDA) levels, and myeloperoxidase (MPO) activity were measured. Hepatic injury, a-smooth muscle actin expression, and stem cell markers c-kit, c-Myc, Oct3/4, and SSEA-1 were histologically determined.

RESULTS

Histological scores, serum ALT, and hepatic MDA levels were higher in BDL group than in the sham rats, while all treatments significantly reduced these levels. The reduction in ALT was significantly greater in UCDA+MT-treated group than in other treatment groups. c-Kit, c-Myc, Oct3/4, and SSEA-1 were increased in saline-treated BDL group with respect to sham-operated control group, and these markers were significantly reduced in all treatment groups.

CONCLUSION

In addition to a modulatory effect on the stem cell-induced regenerative response of the liver, UDCA, MT, and their combination demonstrated similar anti-inflammatory and antiproliferative effects on cholestasis-induced hepatic injury.

摘要

背景/目的:胆汁淤积会导致肝细胞死亡、纤维化、肝硬化,并最终引发肝衰竭,且与氧化应激相关。本研究旨在评估水飞蓟(MT,水飞蓟属植物)和熊去氧胆酸(UDCA)或它们的组合对大鼠肝干细胞激活及胆汁淤积性肝损伤严重程度的影响。

材料与方法

在麻醉状态下,对雌性斯普拉格-道利大鼠进行胆管结扎(BDL)或假手术。BDL大鼠通过灌胃给予生理盐水、UDCA(15毫克/千克/天)、MT(600毫克/千克/天)或UDCA+MT,持续10天。在第11天,处死大鼠并获取血液和肝脏样本。测量血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、肝脏丙二醛(MDA)水平以及髓过氧化物酶(MPO)活性。通过组织学方法确定肝损伤、α-平滑肌肌动蛋白表达以及干细胞标志物c-kit、c-Myc、Oct3/4和SSEA-1。

结果

BDL组的组织学评分、血清ALT和肝脏MDA水平高于假手术大鼠,而所有治疗均显著降低了这些水平。UDCA+MT治疗组的ALT降低幅度显著大于其他治疗组。与假手术对照组相比,生理盐水处理的BDL组中c-Kit、c-Myc、Oct3/4和SSEA-1升高,而所有治疗组中这些标志物均显著降低。

结论

除了对肝干细胞诱导的肝脏再生反应具有调节作用外,UDCA、MT及其组合对胆汁淤积诱导的肝损伤表现出相似的抗炎和抗增殖作用。

相似文献

1
Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.水飞蓟提取物(水飞蓟)、熊去氧胆酸或二者联合治疗可减轻大鼠胆汁淤积性肝损伤:肝干细胞的作用。
Turk J Gastroenterol. 2017 Nov;28(6):476-484. doi: 10.5152/tjg.2017.16742. Epub 2017 Oct 25.
2
The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.熊去氧胆酸对胆管结扎大鼠肝脏氧化应激水平和 DNA 酶活性的影响。
Drug Chem Toxicol. 2013 Apr;36(2):141-8. doi: 10.3109/01480545.2012.658919. Epub 2012 Mar 2.
3
Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.石榴皮提取物可预防胆管梗阻大鼠的肝纤维化。
J Pharm Pharmacol. 2007 Sep;59(9):1287-95. doi: 10.1211/jpp.59.9.0014.
4
Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.维甲酸和熊去氧胆酸联合应用减轻胆管结扎大鼠和人肝细胞肝损伤。
Hepatology. 2011 Feb;53(2):548-57. doi: 10.1002/hep.24047. Epub 2010 Dec 10.
5
Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.桔梗根提取物对胆管结扎诱导的大鼠肝纤维化的保护作用。
Hum Exp Toxicol. 2013 Nov;32(11):1197-205. doi: 10.1177/0960327112474832. Epub 2013 Feb 19.
6
The antioxidant effect of green tea catechin ameliorates experimental liver injury.绿茶儿茶素的抗氧化作用可改善实验性肝损伤。
Phytomedicine. 2010 Mar;17(3-4):197-202. doi: 10.1016/j.phymed.2009.12.006. Epub 2010 Jan 25.
7
Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats.茵陈提取物对胆管结扎诱导的大鼠肝纤维化具有保护作用。
Exp Toxicol Pathol. 2013 Sep;65(6):837-44. doi: 10.1016/j.etp.2012.12.002. Epub 2013 Jan 5.
8
The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats.熊去氧胆酸对婴儿大鼠胆汁淤积性肝纤维化的作用。
Mol Med Rep. 2018 Mar;17(3):3837-3844. doi: 10.3892/mmr.2017.8284. Epub 2017 Dec 15.
9
Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats.熊去氧胆酸在预防大鼠阿莫西林-克拉维酸所致肝毒性中的作用。
Ann Hepatol. 2009 Apr-Jun;8(2):134-40.
10
A study on the protective effect of Silybum marianum extract on hepatic ischemia-reperfusion injury.水飞蓟提取物对肝脏缺血再灌注损伤保护作用的研究
Afr J Tradit Complement Altern Med. 2013 Aug 12;10(5):310-2. doi: 10.4314/ajtcam.v10i5.14. eCollection 2013.

引用本文的文献

1
Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L.水飞蓟素纳米制剂减轻 17α-乙炔基雌二醇诱导的肝内胆汁淤积
BMC Complement Med Ther. 2024 Jan 23;24(1):51. doi: 10.1186/s12906-024-04351-2.
2
Mechanistic Insights into the Pharmacological Significance of Silymarin.水飞蓟宾的药理学意义的机制见解。
Molecules. 2022 Aug 21;27(16):5327. doi: 10.3390/molecules27165327.
3
The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity.中医在肝脏疾病中的潜在应用:一个新机遇。
Front Pharmacol. 2021 Nov 4;12:771459. doi: 10.3389/fphar.2021.771459. eCollection 2021.